We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
-5.55%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$33.8B
AUM Growth
-$2.84B
Cap. Flow
-$310M
Cap. Flow %
-0.92%
Top 10 Hldgs %
26.95%
Holding
1,127
New
219
Increased
335
Reduced
309
Closed
110

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$218M
2
QCOM icon
Qualcomm
QCOM
+$134M
3
KO icon
Coca-Cola
KO
+$112M
4
PG icon
Procter & Gamble
PG
+$111M
5
ORCL icon
Oracle
ORCL
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 20.32%
2 Financials 12.66%
3 Healthcare 12.64%
4 Consumer Discretionary 12.4%
5 Communication Services 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CY
376
DELISTED
Cypress Semiconductor
CY
$12.6M 0.04%
1,475,298
+1,452,465
+6,361% +$15.2M
MYRG icon
377
MYR Group
MYRG
$5.25B
$12.6M 0.04%
478,989
AIV
378
Aimco
AIV
$383M
$12.5M 0.04%
2,541,864
-2,417
-0.1% -$12.2K
HSNI
379
DELISTED
HSN, Inc.
HSNI
$12.5M 0.04%
217,975
MTX icon
380
Minerals Technologies
MTX
$2.34B
$12.4M 0.04%
257,558
+8,000
+3% +$462K
TER icon
381
Teradyne
TER
$59.3B
$12.3M 0.04%
685,749
ODFL icon
382
Old Dominion Freight Line
ODFL
$44.9B
$12.3M 0.04%
605,001
ADPT
383
DELISTED
Adeptus Health Inc
ADPT
$12.3M 0.04%
151,745
+8,684
+6% +$896K
TEN
384
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$12.2M 0.04%
272,802
+117,599
+76% +$5.74M
KAI icon
385
Kadant
KAI
$3.99B
$12.2M 0.04%
312,924
-476
-0.2% -$20.9K
FOLD
386
DELISTED
Amicus Therapeutics
FOLD
$12.1M 0.04%
865,939
+9,621
+1% +$151K
CIEN icon
387
Ciena
CIEN
$58.4B
$12M 0.04%
579,926
+6,478
+1% +$151K
FCFS icon
388
FirstCash
FCFS
$8.78B
$11.9M 0.04%
+297,735
New +$12.2M
HT
389
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$11.8M 0.04%
522,560
SNCR
390
DELISTED
Synchronoss Technologies
SNCR
$11.8M 0.03%
39,850
+5,130
+15% +$1.99M
NBIX icon
391
Neurocrine Biosciences
NBIX
$16.6B
$11.6M 0.03%
292,691
+3,891
+1% +$188K
RPXC
392
DELISTED
RPX Corporation
RPXC
$11.6M 0.03%
848,835
-75
-0% -$1.11K
MEI icon
393
Methode Electronics
MEI
$592M
$11.4M 0.03%
358,940
+1,645
+0.5% +$46.4K
HAYN
394
DELISTED
Haynes International, Inc.
HAYN
$11.4M 0.03%
300,008
INSY
395
DELISTED
Insys Therapeutics, Inc.
INSY
$11.4M 0.03%
398,827
-339,646
-46% -$12.5M
BMTC
396
DELISTED
Bryn Mawr Bank Corp
BMTC
$11.3M 0.03%
364,267
+72,592
+25% +$2.17M
AVNS
397
DELISTED
Avanos Medical
AVNS
$11.3M 0.03%
396,141
+186,907
+89% +$6.52M
NNN icon
398
NNN REIT
NNN
$8.99B
$11.1M 0.03%
307,022
+12,600
+4% +$457K
WCN
399
Waste Connections
WCN
$42B
$11M 0.03%
340,190
SNA icon
400
Snap-on
SNA
$21.5B
$10.9M 0.03%
+71,945
New +$11.5M

Similar funds

Loomis, Sayles & Company's Q3 2015 Portfolio in Review

As of Q3 2015, Loomis, Sayles & Company held 1,127 positions worth $33.8B, down 7.8% from $36.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Loomis, Sayles & Company's Q3 2015 filing shows 219 new, 335 increased, 309 reduced and 110 closed positions. Its largest new stake was Babcock & Wilcox: 199,530 shares worth $33.5M. The largest sale was Amazon, an estimated $138M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Loomis, Sayles & Company's largest Q3 2015 buy was Babcock & Wilcox: 199,530 shares worth $33.5M.
  • Loomis, Sayles & Company added most to Alibaba in Q3 2015, an estimated $218M increase.
  • Loomis, Sayles & Company's biggest Q3 2015 reduction was Amazon, cutting an estimated $138M.
  • Loomis, Sayles & Company fully exited Altera Corp in Q3 2015, selling an estimated $44.6M.
  • Loomis, Sayles & Company's ten largest holdings make up 27% of its $33.8B portfolio in Q3 2015.
  • Loomis, Sayles & Company opened 219 new positions and closed 110 in Q3 2015.
  • Loomis, Sayles & Company's portfolio value fell 7.8% quarter-over-quarter to $33.8B.

Based on Loomis, Sayles & Company's 13F filing for Q3 2015, filed 13 Nov 2015.